Niramai

Early Breast Cancer screening using AI

description

Breast Cancer is the leading cause of cancer in women. It is well-established that early diagnosis is very critical in saving a life of a cancer patient. Co-founded by Geetha Manjunath and Nidhi Mathur, researchers at NIRAMAI have developed a new cancer screening software that uses machine intelligence over thermography images to enable a low cost, easy to use, portable solution and requires minimal human supervision. NIRAMAI solution uses a high resolution thermal sensing device and cloud hosted analytics solution for analysing the thermal images. The SaaS solution uses big data analytics, artificial intelligence and machine learning for reliable, early and accurate breast cancer screening. The innovative methods used in the solution have led to multiple US patents.

founders

Geetha Manjunath

founded

2017

year of investment

Dec 2017

"

why we invested

Breast cancer if detected early can be cured fully. However current methods struggle to do that. Niramai with its patented thermal and AI tech helps detect breast cancer in its very inception.

"

Latest on

Niramai

More from the

folio

Alternative protein using precision fermentation
Life Sciences
Materials
AI chatbot providing accessible mental health therapy.
AI
AI assistant to streamline operations for small businesses
AI